Cannabinoids Fall Short Across Most Psychiatric Disorders - Poll - MDSpire

Cannabinoids Fall Short Across Most Psychiatric Disorders

"[T]he routine use of cannabinoids for the treatment of mental disorders and SUDs is rarely justified."

  • By

  • Kathryn Wighton

  • July 24, 2026

  • 4 min

Share

Original Source(s)

Cannabinoids Fall Short Across Most Psychiatric Disorders

  • by Kathryn Wighton

  • July 24, 2026

Related Content

Why Practices Join Hospital Systems

Interviews with hospital leaders and employed physicians highlighted financial pressures, perceived care-integration benefits, and unresolved operational tensions following acquisition.

Dual-Site Theta Burst Stimulation May Reduce Suicidal Ideation

Four-day treatment targeting the prefrontal cortex and cerebellum produced larger reductions in suicidal ideation scores than prefrontal stimulation alone in adolescents with major depressive disorder.

Distress Tied to Digital Overuse

In a survey of 420 Italian adults, psychological distress showed stronger associations than autistic traits with problematic internet and mobile phone use, although both were associated with higher digital-use scores.